The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy
Andrew T. Lenis(Memorial Sloan Kettering Cancer Center), Karim Chamie(University of California, Los Angeles), Katherine E. Fero(UCLA Health), Leslie Ojeaburu, Wayne Brisbane(University of California, Los Angeles), Vishnukamal Golla(University of California, Los Angeles), Michael Leapman(Yale University), Patrick M. Lec(University of California, Los Angeles)
Urologic Oncology Seminars and Original Investigations
February 24, 2021
Cited by 9
Related Papers
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
|Urologic Oncology Seminars and Original Investigations|2017|250
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169
MicroSegNet: A deep learning approach for prostate segmentation on micro-ultrasound images
|Computerized Medical Imaging and Graphics|2024|76